Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Highly AccessMinireview

The future of artemisinins: natural, synthetic or recombinant?

Marcel Hommel email

Institut Pasteur, 25-28 rue du Dr Roux, Paris 75724 Cedex 15, France

author email corresponding author email

Journal of Biology 2008, 7:38doi:10.1186/jbiol101

Published: 15 December 2008

Abstract

Artemisinins are the most important anti-malarial drugs in use today, but are more costly than previous anti-malarials and production and price tend to fluctuate. Alternative ways of producing artemisinins are discussed here in the light of a recent paper in BMC Biotechnology on improving the yield of the precursor, artemisinic acid, in genetically engineered yeast.


© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.